Awards & Advancement

ERT updates executive management team

Thursday, July 2, 2015 09:36 AM

ERT, a global provider of patient safety and efficacy endpoint data collection, cloud analytics and workflow solutions, has appointed Steve Nuckols executive vice president and chief commercial officer. As chief commercial officer, Nuckols will be responsible for all global business development activities within ERT, with primary focus on ensuring ERT’s products and services best meet the needs of its global pharmaceutical customers.

More... »


Edge Therapeutics’ CEO Brian Leuthner receives EY Entrepreneur of the Year Award

Monday, June 29, 2015 10:43 AM

Brian A. Leuthner, Edge Therapeutics’ CEO, president and co-founder, has received the EY Entrepreneur of the Year 2015 New Jersey Region Award in the Pharmaceutical & Diagnostic Private Companies category. He was selected by an independent judging panel comprising previous winners of the award, CEOs, private capital investors and other regional business leaders.

More... »


DBV Technologies adds Dr. Hugh Sampson as chief scientific officer

Monday, June 29, 2015 10:10 AM

DBV Technologies, a clinical-stage specialty biopharmaceutical company, has appointed Dr. Hugh Sampson chief scientific officer. In partnership with Dr. Dupont, chairman of the company’s scientific advisory board, Sampson will lead DBV’s research team, pursuing new Viaskin applications for the treatment of food allergies, while also supporting the company’s clinical development teams.

More... »

HHS announces innovation award winners

Thursday, June 25, 2015 12:05 PM

Department of Health and Human Services Secretary Sylvia M. Burwell has announced the seven winners of the 2015 HHS Innovates Awards. This annual award program, in its eighth round, recognizes creative solutions developed by HHS employees in response to some of the nation’s most challenging problems in health, health care and government. Winners this year reflected a number of collaborative innovation projects representing seven different operating divisions.

More... »

NIH Council of Councils members named

Monday, June 22, 2015 12:39 PM

The National Institutes of Health has announced the appointment of eight individuals to the NIH Council of Councils. The council was established to advise the NIH director on policies and activities of the Division of Program Coordination, Planning, and Strategic Initiatives (DPCPSI), including making recommendations on research that represents important areas of emerging scientific opportunities, rising public health challenges, or knowledge gaps that deserve special emphasis or would otherwise benefit from strategic planning and coordination.

More... »

PhRMA elects new members of board of directors

Monday, June 22, 2015 12:26 PM

The Pharmaceutical Research and Manufacturers of America (PhRMA) has announced the election of five of its newest members to its board of directors.

More... »

Syndax appoints Dr. Briggs Morrison CEO, Michael Metzger president and COO

Monday, June 15, 2015 01:43 PM

Syndax Pharmaceuticals, a privately held oncology company based in Waltham, Mass., has announced that Briggs W. Morrison, M.D., is joining the company as CEO and a member of the board of directors, and Michael A. Metzger is joining the company as president and chief operating officer. Morrison joins Syndax from AstraZeneca, where he was executive vice president, global medicines development and chief medical officer. Metzger joins from Regado Biosciences, where he was president and CEO through the company's strategic merger with Tobira Therapeutics.

More... »

Plasticell appoints Dr. Aaron T. T. Chuang as chief scientific officer

Monday, June 15, 2015 01:42 PM

Plasticell, a regenerative medicine company utilizing combinatorial technologies for stem cell research and in developing cell therapies, has recruited Dr. Aaron Chuang to its executive management team in the role of chief scientific officer. Previously, Chuang was research director at the regenerative medicine unit of GlaxoSmithKline, where he worked for over 18 years. As Plasticell’s chief scientific officer, Chuang takes on responsibility for preclinical therapeutic programmes, scientific oversight of collaborations and alliances, as well as external scientific communications. 

More... »

CPhI Pharma Awards 2015 open with five new categories

Monday, June 15, 2015 01:38 PM

CPhI Worldwide, organized by UBM EMEAhas opened the annual CPhI Pharma Awards for 2015, with five new categories covering the entire pharmaceutical supply chain. Now in their 12th consecutive year, the awards will honor companies and individuals driving the pharma industry forward through innovations, new approaches, technologies and strategies.  

More... »

ClinTec International expands into South Africa

Monday, June 15, 2015 01:36 PM

Global CRO ClinTec International has expanded with a Regional Hub Office for Sub-Saharan Africa in Johannesburg, South Africa. Aligning with new client partnerships, the office will support region wide clinical research services including a significant new clinical FSP assignment with a global biotechnology major where ClinTec is the sole FSP partner for South Africa. 

More... »

CWWeekly

June 29

FDA and PatientsLikeMe collaborate to test social media adverse event reporting

Boston-area teaching hospitals launch web portal to attract life science companies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs